Treatment with Bifidobacterium longum 51A attenuates intestinal damage and inflammatory response in experimental colitis.
- 2020-02-19
- Beneficial Microbes 11(1)
- F. A. Abrantes
- B. B. Nascimento
- M. E. Andrade
- P. A. V. de Barros
- C. T. Cartelle
- F. S. Martins
- J. Nicoli
- R. Arantes
- S. Generoso
- S. O. Fernandes
- V. Cardoso
- PubMed: 32066260
- DOI: 10.3920/bm2019.0098
- Low evidence
Bifidobacterium administration in the T group showed reduction in intestinal permeability and lower IL-1β, myeloperoxidase, and eosinophil peroxidase levels compared to those in the colitis group (P<0.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes